Synergistic interaction of selected marine animal anticancer drugs against human diffuse large cell lymphoma

@article{Mohammad1998SynergisticIO,
  title={Synergistic interaction of selected marine animal anticancer drugs against human diffuse large cell lymphoma},
  author={R. Mohammad and G. Pettit and V. P. Almatchy and N. Wall and M. Varterasian and Ayad M. Ai-Katib},
  journal={Anti-Cancer Drugs},
  year={1998},
  volume={9},
  pages={149–156}
}
  • R. Mohammad, G. Pettit, +3 authors Ayad M. Ai-Katib
  • Published 1998
  • Biology, Medicine
  • Anti-Cancer Drugs
    • We studied the antitumor effects of dolastatin 10, its structural modification, auristatin PE (TZT-1027), and vincristine alone and in combination with bryostatin 1 on a human diffuse large cell lymphoma line (WSU-DLCL2) in vitro and in vivo. WSU-DLCL2 cells were cultured in RPMI 1640 at a concentration of 2 × 105/ml using a 24-well plate. Agents were added to triplicate wells, and cell count, viability, mitosis and apoptosis were assessed. Dolastatin 10 showed no apparent inhibition of cell… CONTINUE READING
    View on Wolters Kluwer
    ncbi.nlm.nih.gov
    20 Citations
    Background Citations
    3
    20 Citations
    Citation Type

    Citation Type

    Induction of Apoptosis in Mice with B16 Melanoma by Treatment with the Antimicrotubule Agent TZT-1027
    • 4
    Auristatin PYE, a novel synthetic derivative of dolastatin 10, is highly effective in human colon tumour models.
    • 21
    • PDF
    TZT‐1027, an Antimicrotubule Agent, Attacks Tumor Vasculature and Induces Tumor Cell Death
    • 73
    Potentiation of the activity of cisplatin in a human colon tumour xenograft model by auristatin PYE, a structural modification of dolastatin 10.
    • 7
    Phase II study of dolastatin-10 in patients with hormone-refractory metastatic prostate adenocarcinoma.
    • 119
    Phase II Study of Dolastatin-10 in Patients with Hormone-refractory Metastatic Prostate Adenocarcinoma 1
    • 6
    • PDF
    Bryostatin 1 induces differentiation and potentiates the antitumor effect of Auristatin PE in a human pancreatic tumor (PANC-1) xenograft model
    • 13
    CHAPTER 12 – BIOSYNTHETIC PRODUCTS FOR ANTICANCER DRUG DESIGN AND TREATMENT: THE BRYOSTATINS
    • 14
    Pharmacology and clinical experience with bryostatin 1: a novel anticancer drug.
    • Philip, Zonder
    • Medicine
    • Expert opinion on investigational drugs
    • 1999
    • 27
    Marine Mollusk‐Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance
    • 27